Flavia Melotti

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Correction to: Immunoglobulin light chain transcript detection by ultrasensitive RNA in situ hybridization for B-cell lymphoma diagnosis.

Correction to: Immunoglobulin light chain transcript detection by ultrasensitive RNA in situ hybridization for B-cell lymphoma diagnosis.

Journal: Virchows Archiv : an international journal of pathology

Published: November 16, 2023

Immunoglobulin light chain transcript detection by ultrasensitive RNA in situ hybridization for B-cell lymphoma diagnosis.

Immunoglobulin light chain transcript detection by ultrasensitive RNA in situ hybridization for B-cell lymphoma diagnosis.

Journal: Virchows Archiv : an international journal of pathology

Published: May 22, 2023

Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience.

Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience.

Journal: Frontiers in oncology

Published: April 18, 2023

Gastroblastoma in Adulthood-A Rarity among Rare Cancers-A Case Report and Review of the Literature.

Gastroblastoma in Adulthood-A Rarity among Rare Cancers-A Case Report and Review of the Literature.

Journal: Case reports in pathology

Published: June 04, 2019

Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine.

Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine.

Journal: Oncotarget

Published: August 16, 2016

Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases.

Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases.

Journal: Medical oncology (Northwood, London, England)

Published: May 01, 2015

A subset of genetic susceptibility variants for colorectal cancer also has prognostic value.

A subset of genetic susceptibility variants for colorectal cancer also has prognostic value.

Journal: The pharmacogenomics journal

Published: September 29, 2014

TP53 mutations in advanced colorectal cancer: the dark side of the moon.

TP53 mutations in advanced colorectal cancer: the dark side of the moon.

Journal: Oncology

Published: December 16, 2013

Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoids.

Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoids.

Journal: British journal of cancer

Published: August 02, 2013

Role of BAX for outcome prediction in gastrointestinal malignancies.

Role of BAX for outcome prediction in gastrointestinal malignancies.

Journal: Medical oncology (Northwood, London, England)

Published: March 20, 2013

Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients.

Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 18, 2012

A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples.

A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples.

Journal: Anticancer research

Published: April 12, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026